Explore comprehensive CDMO, CRDMO and CRO services offered by Wuxi XDC, supporting end-to-end Anlaytical Testing, Drug Development, Manufacturing and Packaging. Wuxi XDC enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: China, Singapore
Description: WuXi XDC is a global Contract Research, Development, and Manufacturing Organization (CRDMO) specializing in Antibody Drug Conjugates (ADCs) and other bioconjugates. It offers integrated, end-to-end services from early-stage discovery to commercial manufacturing, covering components like antibody and payload-linkers, as well as the final drug substance and product. WuXi XDC provides an open-access platform to help biopharmaceutical partners accelerate the development of these complex therapies.
